An Intercompany Perspective on Practical Experiences of Predicting, Optimizing and Analyzing High Concentration Biologic Therapeutic Formulations.
J Pharm Sci
; 112(2): 359-369, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36442683
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
J Pharm Sci
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos